(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
Cannabis in Cosmetics; Where Are We Now

Cannabis in Cosmetics; Where Are We Now

by Emily C | Apr 28, 2020 | Canadian Regulatory, Cosmetics, Innovation, Natural Health Products, OTC Drugs, Research/Science/Technology, U.S. Regulatory

A couple of years ago the world began legalizing recreational cannabis, bringing it into the cosmetic industry. Since then, it has been reported that the cosmetic CBD market has a net worth of 710 million US dollars and is projected to have a net worth of 959 million...
Health Canada Guidance Document on Interim Expedited Hand Sanitizer Approval Process

Health Canada Guidance Document on Interim Expedited Hand Sanitizer Approval Process

by Emily C | Apr 16, 2020 | Canadian Regulatory, Natural Health Products

Health Canada has released a guide document pertaining to the temporary expedited process for the production and distribution of hand sanitizers in Canada. The document highlights acceptable quality grades and medicinal ingredient concentrations, formulation...
A Summary of International Efforts in Minimizing the Spread of COVID-19

A Summary of International Efforts in Minimizing the Spread of COVID-19

by Emily C | Apr 3, 2020 | Canadian Regulatory, Innovation, Medical Devices, Research/Science/Technology, U.S. Regulatory

Recently, information has been provided regarding updates that Health Canada and the U.S. FDA have done in order to aid in the battle against COVID-19. However, other countries have also taken drastic measures to assist with reducing the spread of COVID-19. The...
Health Canada Extension on Nitrosamine Risk Assessments

Health Canada Extension on Nitrosamine Risk Assessments

by Emily C | Apr 3, 2020 | Canadian Regulatory, Medical Devices, Natural Health Products, Research/Science/Technology

Earlier this year, information about new regulations and requirements put in place by Health Canada for product’s containing nitrosamine impurities was released. These regulations are applicable to prescription and non-prescription pharmaceuticals containing...

Recent Posts

  • Interferon Beta 1a: Potentially Promising Treatment for Covid-19
  • The Sunshine Vitamin: What, Where, and How Much?
  • A Risk-Based Approach to Site License Applications
  • COVID-19 and Vitamin D: Correlation or Coincidence?
  • New Canadian Cosmetic Ingredient Hotlist Updates

Recent Comments

    Archives

    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2020 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     


    Jennifer Porter

    Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

    Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.